Lysine specific demethylase 6A/B (KDM6A/B), histone lysine demethylases targeting H3K27me3, have emerged as key regulators of inflammatory gene expression and are increasingly implicated in the pathogenesis of inflammatory bowel disease (IBD). However, there remains a critical need for potent, selective, and cell-activ...
Yu-Qi Tang, Xin Hu, An-Cheng Shen et al.· European journal of medicina...· 0 citations
Immune checkpoint blockade (ICB) has reshaped the therapeutic landscape of solid tumors. However, durable clinical benefit remains limited to a subset of patients because of primary or acquired resistance. Beyond tumor-intrinsic factors, the tumor microenvironment (TME) plays a critical role in shaping responsiveness t...
Luo-Man Gan, Zhong-Long Liu, Li-Ren Cao et al.· Experimental Hematology & On...· 0 citations
KDM6A phosphorylation is identified as a druggable epigenetic-immune checkpoint and mRNA-based modulation of enzyme post-translational status as a transformative paradigm to potentiate ICB in HNSCC is established.
Yi-Kang Ji, Xin-Ran Zhao, Cheng Hu et al.· Cell Death & Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.